Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
LEARNING OBJECTIVES:
- Describe how pretreatment with dual antiplatelet (DAP) therapy impacted the rate of various safety outcomes in patients treated with IV thrombolysis in this study
- Discuss how, after controlling for other confounders, DAP pretreatment was independently associated with various safety and efficacy outcomes following treatment with IV thrombolysis in this study
- Identify patient subgroups in study in whom DAP pretreatment was associated with an excess risk of various safety outcomes following IV thrombolytic treatment
Credit Types: | CME |
Credit Amount: | 0.75 Credits |
Release Date: | 2018-Sep-11 |
Expiration Date: | 2021-Sep-11 |
Registration Required: | Yes |
Cost: | $807/yr |
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.